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ABSTRACT 
 
Study Objective: To examine the effectiveness of acapella along with 
conventional therapy in improving Lung function in chronic asthma. 
 
Participants: 30 subjects with chronic asthma were selected. They were 
divided into control group and experimental group with 15 patients each. 
Outcome measure: The outcome measurement is done by peak 
expiratory flow meter (PEFM) and medical research clinical dyspnoea 
scale (MRC) 
Result: Both groups showed significant improvement in lung function 
after the therapy program .The experimental group showed a statistically 
significant improvement in pulmonary function when compared to the 
control group at 5 % level of significance. 
 
Conclusion: Treatment with the – acapella along with conventional 
physiotherapy showed a significant improvement in lung function and 
dyspnoea than control group. It can be used as an effective treatment in 
improving the expiratory flow rates .A well designed trial is needed to 
study the effectiveness of  acapella in improving lung function in a   large  
group and to know its long term effect. 
 
Keywords: Acapella, Chronic Asthma, Dyspnoea, Lung function 
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CHAPTER I 
    1.1 INTRODUCTION  
  Asthma is a chronic inflammatory disorder of the airways in which many 
cells and cellular elements play a role, in particular mast cells, eosinophils, T 
lymphocytes, neutrophils and epithelial cells. This inflammation causes recurrent 
episodes of wheezing, breathlessness, chest tightness and cough (Jessica H. Boyd 
and Robert C. Strunk). 
  
    Asthma is a very common disease with immense social impact. The 
prevalence of asthma has increased significantly since the 1970s. As of 2009, 300 
million people were affected world wide. It is estimated that asthma has 7-10% 
prevalence worldwide. While asthma is a more common in affluent countries, it is by 
no means a restricted problem; the WHO estimate that there are between 15 and 20 
million people with asthma in India. Striking increases in asthma prevalence have 
been observed in populations migrating from a rural to an urban one.  
 
   Asthma occurs at all ages but predominantly in early life that one half of the 
cases develop before age of 10 and another third occur before the age of 40. In 
childhood there is 2:1 male/female preponderance, but sex ratio equalizes by age 30 
(Gina – 2006). 
 
     Asthma is characterized by several changes in the airways including 
smooth muscle hyperplasia, thickening of the basement membrane, and denudation of 
epithelial cells, airway tissue edema and mucosal gland hypertrophy.  
                                  
     Airway inflammation plays a central role in asthma this contributes to 
airflow limitations through bronchus constriction, mucus production and airway 
edema. Allergic inflammation characterized by increased levels of immunoglobulin E, 
stimulates and immune response driven by TH2 lymphocytes, which activate mast 
cells, macrophages and other proinflammatory mediators. This cascade leads to the 
contraction of smooth muscles in the airway, increased secretion of mucus into the 
airway and vasodilatations of airway vessels. (Chiappara – 2001) 
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     The airway inflammation in asthma leads to variable levels of lower airway 
obstruction that affects both the small and large airways. Recurrent airflow limitation 
is caused by bronchoconstriction, airway edema, chronic mucus plug formation and 
airway remodelling. Airway hyper responsiveness is associated with airway 
inflammation and underlies the presentation of symptoms in asthma. Hyper 
responsiveness not only contributes the symptoms of bronchoconstriction and airflow 
limitations, but also has been shown to be associated with a decline in lung function. 
(Lauren Robertson et al – 2007) 
 
      In asthma airway remodelling represents the healing and alterations in the 
airway that occurs due to chronic inflammation. Mucus glands are increased in 
number, affecting the thickness of the airway wall and increase in mucus secretion. 
The inflammatory exudates that increase surface tension and promote closure of 
airway. The reticular basement membrane also becomes thickened with deposition of 
collagens, these changes results in increasing thickness of airways and exaggerates the 
airway obstruction. 
  
              Traditionally physiotherapy applies various techniques and modalities, chest 
clapping or cupping has been replaced by the use of inflatable vests or mechanical 
vibrators applied to the chest. Oral devices that apply positive end expiratory pressure 
maintain the patency of the airway during exhalation and accomplish many of the 
same goals as postural drainage in a shorter time and with less discomfort. Chest 
physiotherapy forms an integral part of the management of bronchial secretions. 
There are several chest physiotherapy techniques or devices aimed at removing 
bronchial secretions (Jennifer.A.Pryor – 2008). The oscillatory positive expiratory 
pressure device plays an important role in bronchial hygiene, which consists of a 
mechanical oscillatory device called the acapella (Alves.C.E -2010). It is an easy to 
use physiotherapy device, combines safe endobronchial positive expiratory pressure 
with vibratory and oscillatory effects. Vibratory devices work by oscillating 
vibrations that travel into the lungs.  The acapella is a hand held device causing an 
oscillatory positive expiratory pressure within the airways, has been proposed as an 
alternative to more conventional airway clearance techniques (A.J.Ragavan – 2010). 
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              The peak expiratory flow is one component of the flow volume manoeuvre. 
This has been encouraged by the availability of simple devices for its measurement .It 
also provides a tool for patients to use to monitor their asthma objectively (Ma 
Lourdes – 2004). 
 
              Dyspnoea can be measured in a variety of ways. The Medical research 
council dyspnoea breathlessness score is self administrated, grades dyspnoea during 
walking according to five levels, with grade 5 representing patients who consider 
themselves home bound due to breathlessness. 
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1.2. NEED OF THE STUDY  
  
The major goal of a physiotherapist is to optimize a patient’s lung function. 
Increasing lung volume causes a reduction in airway resistance and improves 
ventilation. The acapella breathing treatment is a form of bronchial hygiene therapy 
for patients who are having trouble in clearing secretions from the airway. Normal 
airway clearance requires an effective cough with ciliated epithelial cells that move 
mucus towards the trachea and larynx where the excess secretion can be expectorated. 
Respiratory physiotherapy is essential to the treatment of all acute or chronic 
respiratory disorders in which expectoration difficulties are major problems.   
 
         This study is focused on the restoration of lung volumes normal by oscillatory 
positive expiratory pressure, its effectiveness in asthma using acapella and to examine 
its effectiveness in the management of asthmatics independently for airway mucus 
clearance and improvement in lung function and reducing dyspnoea of patients with 
chronic asthma. 
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 1.3. OPERATIONAL DEFINITION 
 
ASTHMA: 
Asthma is a disease characterized by increased responsiveness of the bronchi 
to various stimuli, manifested by widespread narrowing of the airways that changes in 
severity either spontaneously or as a result of treatment (Robert.L.Souhami). 
 
DYSPNOEA: 
It is defined by the American thoracic society as the subjective sensation of 
breathing discomfort that consists of qualitatively distinct sensations that vary in 
intensity (American thoracic society). 
 
ACAPELLA (Oscillatory positive expiratory pressure device): 
It is a hand held device that combines the resistive features of a positive 
expiratory pressure with oscillation and can be used in virtually any spatial 
orientation, a device that combines the oscillations of air within the airways during 
expiration and a positive expiratory pressure therapy (Alves.C.E). 
 
PEAK EXPIRATORY FLOW RATE 
 The peak expiratory flow rate measures how fast a person can breathe out 
(exhale) air. It is one of many tests that measures how lung well working.(Andrew 
Schriber) 
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      1.4. AIM OF THE STUDY 
 
To examine the effectiveness of acapella an oscillatory positive expiratory 
pressure device to be more helpful than conventional physiotherapy for airway 
mucus clearance, in improving lung function. 
   
 
 
 
  
     1.5. OBJECTIVES OF THE STUDY 
 
1.  To find out the effectiveness of Acapella along with conventional 
physiotherapy in improving pulmonary function in chronic asthma patients 
.  
2. To establish the effectiveness of Acapella along with conventional 
physiotherapy in improving lung function in chronic asthma patients. 
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 1.6. HYPOTHESIS 
 
ALTERNATE HYPOTHESIS: 
 
              Conventional physiotherapy with the acapella is more effective than 
conventional physiotherapy in improving lung function in patients with chronic 
asthma. 
 
 
 
NULL HYPOTHESIS: 
 
          Conventional physiotherapy with acapella is not more effective than 
conventional physiotherapy in improving lung function in patients with chronic 
asthma. 
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CHAPTER II 
                               REVIEW OF LITERATURE 
 
1) World Health Organisation (2005-2006): Asthma is a chronic disease 
characterized by recurrent attacks of breathlessness and wheezing, which vary in 
severity and frequency from person to person. During an asthma attack, the lining of 
the bronchial tubes swells, causing the airways to narrow and reducing the flow of air 
into and out of the lungs. 
 
2) Global Initiative For Asthma (2005): Asthma is a chronic inflammatory disorder 
of the airways in which many cells and cellular elements play a role. The chronic 
inflammation causes an associated increase in airway hyper responsiveness that leads 
to recurrent episodes of wheezing, breathlessness, chest tightness and coughing, 
particularly at the night or in the early morning. These episodes are usually associated 
with widespread but variable airflow obstruction that is often reversible either 
spontaneously or with treatment 
 
4)  Gina (2009): Asthma is one of the most common chronic diseases with an 
estimated 300 million individuals affected world wide. Its prevalence is increasing, 
especially among children 
 
5) Stephen T. Holgate (2008): Airway inflammation in asthma is a multicellular 
process involving mainly eosinophils, neutrophils, T lymphocytes and mast cells with 
eosinophillic infiltration the most striking feature. As the disease becomes more 
severe and chronic the inflammatory infiltrate spreads more proximally and distally. 
In chronic asthma the number of goblet cells that secrete the viscous mucus increases, 
with parallel reduction in ciliated cells. Since mucus production is fundamental to the 
pathogenesis of chronic asthma, this metaplastic change in the airway epithelium is of 
great importance in the more peripheral airways which are devoid of goblet cells. 
 
6) Nakagome. et.al. (2011): Bronchial asthma is a chronic disorder characterized by 
airway inflammation, reversible airway obstruction, and airway hyper responsiveness. 
Eosinophills are believed to play an important role in the pathogenesis of asthma 
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through the release of inflammatory mediators. In severe asthma, not only eosinophils 
but also mast cells or neutrophils play important roles. Mast cells are much infiltrated 
to smooth muscle in severe asthma and induce airway remodelling by release of 
inflammatory mediators 
 
7)  Joanne Douglas M (2005):  
It has been long recognized that asthma is a disease of eosinophilic airway 
inflammation. In patients with airway inflammation is suggested by -Charcot Leyden 
crystals (derived from the cytoplasm of the eosinophills) Creola bodies (clumps of 
desquamated epithelial cells) 
Crushmann spirals (twisted casts of airways consists of glycoprotein’s cores around 
which many fibrils are bound).Increased mast cells activation in the airways and 
subsequent degranulation.Mast cells release cytokines and chemokines that recruit 
eosinophils, basophills and T-lymphocytes to the local mucosa. 
Ongoing inflammation results in structural changes within the airways .This leads to 
as airway remodelling and includes epithelial damage, basement membrane 
thickening and hypertrophy of smooth muscle and mucus glands, leading to increased 
bronchial hyper responsiveness and airflow obstruction. 
 
8) Gina (2006): 
Airway narrowing is the final common pathway leading to symptoms and 
physiological changes in asthma. Several factors contribute to development of airway 
narrowing in asthma; airway smooth muscle contraction, airway edema, airway 
thickening and mucus hypersecretion. 
 
9)  Orihara K. (2009): Tissue remodelling is now an integral element of asthma 
pathophysiology. Pathophysiology of asthma generally inflammatory, immune and 
structural cells as well as a wide range of mediators. An intricate network of 
mediators, released from both immune and inflammatory cells. 
 
10) Jennifer Pryor (2008): The main problem in asthma is a chronic inflammatory 
process within the airway resulting in recurrent episodes of wheezing, breathlessness 
and cough, There is increased responsiveness of the smooth muscles in the bronchial 
walls to various stimuli. Hypertrophy of the mucus glands may lead to mucus 
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plugging .These changes cause variable airway obstruction which may become 
chronic and severe. 
11)  Nancy et al (1990): Three measurements of PEFR were obtained by using 
calibrated mini-Wrights peak flow meter. PEFR was strongly related to age, sex and, 
height. After adjustments for these factors, low PEFR was associated with chronic 
respiratory symptoms cough, wheeze, and shortness of breath, exertional dyspnoea, 
orthopnoea and paroxysmal nocturnal dyspnoea. PEFR was strongly related to 
measures of functional ability and physical activity, self-assessment of health and 
simple measures of cognitive function.  
 
12) Tsukiokak (2001): Peak Expiratory Flow Meter: Controlling drugs and relieving 
drugs as prescribed for many of the patients and they use their drugs when their 
symptoms are getting worse. Patients tent to underestimate their symptoms, since they 
cannot evaluate their airway obstruction correctly. It is known that patients with out 
PEFM are at a higher risk of dying from asthma. This attempts to infer the 
significance of peak expiratory flow and peak flow meter especially in the 
management of adult asthmatics. 
 
13) Ma Lourdes. B (2004): Cost effectiveness and cost-benefit analysis reveal that, a 
peak flow based asthma education and self-management plan is the most effective 
alternative in reducing costs associated with ER visits and hospitalization due to 
asthma exacerbation. 
 
14) Peter.J. Barnes (2002): An important tool for the diagnosis and subsequent 
treatment of asthma is the use of peak expiratory flow meters to measure peak 
expiratory flows. PEF is a simple, reproducible index and can be measured with 
inexpensive and portable PFM. For most asthmatic patients PEF monitoring should be 
done at least   in morning or awakening and in the evening hrs .Its also useful in 
assessing the severity of asthma and its response to treatment. Its effort dependent and 
mainly caliber of large airways and therefore underestimate the degree of airflow 
limitation in peripheral airways .A diurnal variability of more than 20% is diagnostic 
of asthma. PEF reflects the patency of central airways and thus may underestimate the 
airflow limitation particularly in the peripheral airways. 
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15) Darbee et al (2006): 
The MRC Dyspnoea scale is an easy to use tool to document the impact of dyspnoea 
on a persons physical functioning. It has acceptable reliability and validity for use as a 
measurement tool and is sensitive to change. As such, this outcome measure provides 
clinicians with the ability to quantify dyspnoea and to monitor changes in dyspnoea in 
response to physical therapy interventions. 
 
16) Martinez et al (2003): 
Dyspnoea is a main feature of symptomatology in asthma, and its perception does not 
necessarily correlates well with airway obstruction. MRC and Borg clinical dyspnoea 
scales showed significant information in subjects with asthma. 
 
17) Roland Buhl et al [2010]: MRC dyspnoea scale is a simple and standardized 
method of categorizing disability. The patient selects a grade on the self-applied 5-
point instrument that describes everyday situations or activity levels provoking 
breathlessness and impairment. 
 
18) BTS (2001): 
Patient selection for pulmonary rehabilitation- 
The benefits of rehabilitation may apply to all patients with dyspnoea from respiratory 
disease, the introduction rehabilitation become appropriate when patients become 
aware of their disability, some patients with cardiac or locomotors disability may not 
benefit as much 
 
19) Anna Murphy (2007): Pulmonary rehabilitation involves exercise training, 
counselling, and education. The exercise component of the program is personalized to 
the patient’s capabilities and individual goals. Current guidelines states that the 
exercise component of pulmonary rehabilitation should consist of aerobic exercises to 
achieve generalized strengthening of the peripheral muscles. 
 
 
20) Jennifer. A. Pryor (2008): Pulmonary rehabilitation is an effective therapy, 
pulmonary rehabilitation programme results in; Improvement in exercise tolerance, 
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Improvement in the sensation of dyspnoea, Improvement in the ability to perform   
activities of daily living, Improvement in health related quality of life, Improvement 
in muscle strength, endurance masses and Reductions in number of days spent in the 
hospital. Pulmonary Rehabilitation is considered to be an important therapeutic 
intervention. 
 
21) Alves C.E. (2010): 
Mechanical Analysis of an Oscillatory Positive Expiratory Pressure device used in 
Respiratory Rehabilitation: Acapella® Blue device produces oscillation in the   ranges 
of ciliary movements and respiratory system resonance frequency of patients with 
respiratory diseases. This aims to characterize the mechanical behaviour, blue, a 
respiratory rehabilitation device designed to aid in sputum clearance .In this peak to 
peak oscillation amplitude (App) and peak frequency (fp) and positive pressure level 
(ppl), in the flow range more commonly found in practice. The parameters were 
evaluated in all 5 adjustment levels of the equipment in intervals of 50 ml/s.The 
device may produce oscillation in the ranges of ciliary movements and respiratory 
system resonance frequency of patients with respiratory diseases .Data obtained in 
this work help to optimize the use of the acapella blue device in respiratory 
rehabilitation. 
 
22) A.J.Ragavan (2010): The study demonstrated superimposed oscillations at high 
frequency generated by the acapella device resulted in significant increases in 
displacement of mucus during cough. Acapella vibrates the airways internally 
loosening the mucus that can be coughed out. Clearance of airway mucus during 
cough is most effective with more gel - like mucus with airflow oscillations. 
 
23) Magady A.H. et al (2010): Evaluation of the single and combined roles of 
oscillatory positive expiratory device and conventional chest physiotherapy 
techniques in mechanically ventilated chronic obstructive pulmonary disease patients. 
Acapella device is a good to daily chest physiotherapy procedures in mechanically 
ventilated with high success rate and can replace the exhausting, costly and time 
consuming conventional procedures in such patients. 
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24) Carlos Eduardo Alves (2009): 
Acapella device may produce clinically adequate values of mean pressure and 
oscillation frequency. However it depends on its use at optimized conditions. The user 
friendly software proposed in this study could help the user to achieve these 
conditions. 
 
25)  Janet E. Patterson (2005): 
Airway clearance in Bronchiectases “A randomized crossover trial of ACBT versus 
Acapella. Acapella is as effective a method of airway clearance as ACBT and   may 
offer a user-friendly alternative to ACBT for patients with bronchiectasis. 
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CHAPTER III 
 MATERIALS AND METHODOLOGY 
   
   3.1 MATERIALS 
                    Acapella (OPEP) Blue and Green 
                     Pillow  
                     Sputum cup 
                     Evaluation chart  
                     Data collection sheet 
                     Consent form  
                     Chronic Asthma questionnaire form. 
                     Peak Expiratory Flow Chart 
            Medical Dyspnea Clinical Research Scale 
 
 3.2 METHODOLOGY  
  
 3.2.1 Study Design  
                           The Research approach for the study was an experimental study 
design. 
 
  3.2.2 Study Sample 
                        Non probability convenient sampling technique method will 
randomly assigned to experimental and control group of 15 subjects each. 
  
  3.2.3 Sample Size 
   Sample size consists of 30 chronic asthma subjects. 
 
   3.2.4 Study Method 
  Group A (Control group) - receives conventional physiotherapy. 
               Group B (Experimental group) - receives conventional physiotherapy with 
the acapella device. 
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   3.2.5 Selection Criteria 
           Inclusion Criteria :  
• Age group between 50 to 60 years 
• Chronic asthma patient selected according to the chronic asthma       
questionnaire. 
• Both male and female patients. 
 
             Exclusion Criteria :  
• Active seizures 
• Active haemoptysis 
• Epistaxis 
• Nausea. 
• Increased  intracranial pressure 
• Mental or cognitive impairments 
• Patients who are under regular bronchodilator drugs. 
• Patients with any cardiovascular problems. 
• Uncontrolled hypertension and hypotension 
• Patients with any neurological problems. 
• Patients with infectious disease like tuberculosis and bacterial infections 
• Pulmonary edema and pulmonary embolism. 
• Patients with musculoskeletal problems. 
 
 3.2.6 Study Setting 
   S.H.Medical Centre Kottayam 
            
 3.2.7 Duration of study 
   Total duration of study is six months 
                 
 3.2.8 Parameters 
   Peak Expiratory Flow Meter values  
                       MRC dyspnoea scale values          
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 3.2.9 Statistical Tool 
                 Non-parametric statistical tests  
                                     Mann Whitney “U” Test.     
                                     Wilcoxon Signed Rank Tests. 
 
                  Parametric test namely:                                
                                     Two Sample “t” tests  
                                     Paired “t” test  
 
Mann Whitney “U” Test:                                                      
             This is a non-parametric test for testing whether two population means are 
equal. This test is applied on the pretest scores of group A and group B to confirm that 
the two independent samples were homologous and thereby to make the results 
obtained acceptable. This tests was applied on the post test scores of group A and 
group B to confirm that the two independent groups show a significant difference in 
the results obtained and thereby, to find the effectiveness of the treatment intervention 
over the other group.     
                 
U= n1 n2 + n1 (n2+1)- R1 
                            2 
 
Where n1, n2 are sample sizes,  
R1 be the sum of the ranks given to the observations in the Group A. 
Calculate the value of “U”  
 
Wilcoxon Signed Rank Test:                      
This test is used for testing whether two population means are equal in the 
case of related samples that is analysing the pre and post-test values of Group A and 
also of Group B separately to conclude whether the treatment intervention is effective 
or not. We consider the differences di= xi-yi, where xi and yi are the values before and 
after treatment for the ith individual. Then assign ranks to these differences ignoring 
signs. Then assign the respective signs to the ranks Find the sum of positive ranks and 
sum of negative ranks say T+ and T-. 
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Then Wilcoxon statistic is, 
W= Mean (T+, T-). 
Calculate the value of W or corresponding value of Z 
  
Two-Sample t Test: 
This test is used for testing the equality of means of two groups  
Test statistic used is,                  
 
          The test statistic used is,  
                        x1 -    x2 
   t =                         
n1s12 +  n2 s22      1   +  1      
                       n1+n2- 2         n1       n2     
  
                      
This follows a “t” distribution with (n1+n2-2) degrees of freedom 
Here x1 = sample mean of Group A. 
         x2 = sample mean of Group B. 
         s1 = sample variance of Group A. 
         s2 = sample variance of Group B. 
         n1 = sample size of Group A. 
         n2 = sample size of Group B. 
Calculate the value of “t” and look at the significance level. If the significance level is 
less than 0.05 we reject the null hypothesis at 5% level of significance 
  
 Paired “t” test: 
This test is used for testing the equality of means of Group A and Group B. 
The test statistic used is, 
 
 
 
That follows a t distribution with (n) degrees of freedom. 
t = d     n-1 
             sd  
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Here di = xi-yi.   Xi and yi are the values before and after the treatment and di is the 
AM of the d values. 
Sd is the SD of the d values and n is the sample size. 
Calculate the value of the test statistic “t” and look at the significance level .If the 
significance level is less than 0.05 we reject the null hypothesis at 5% level of 
significance. 
 
3.2.10 Techniques 
(GROUP A) Control Group  
Received conventional physiotherapy which includes,  
 
Education :( 5 minutes) 
 Educating the patient and family about the technique for smoking cessation 
and the dangers associated with smoking; patients should be encouraged to quit 
smoking. Education regarding the preventive measures such as on keeping pets 
outdoors, on using a mask for dusty jobs, avoiding spray polishes, exposure to 
pollutants and on avoiding certain foods that are allergic. 
 
Relaxation Positions :( 10 minutes) 
 Educate the patients regarding the relaxed positions to be adopted during an 
attack of breathlessness. The relaxation positions for a breathless patient are in  
• High side-lying  
• Forward lean sitting  
• Relaxed sitting  
• Forward lean standing   
• Relaxed standing 
 
Breathing Techniques :( 10-Minutes) 
Pursed lip breathing- The patient is instructed to inhale through the nose and exhale 
slowly through the pursed lips. So encourage the patient to use pursed lip breathing 
especially in dyspnoeic episodes to reduce the difficulty of breathing. (5 times per 
session). 
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Breath Control During Walking :( 5 Minutes) 
 Teaching correct breathing pattern with expiration to inspiration ratio 2:1, and 
expiration for the first two steps and inspiration for the next one step. 
 
 Chest Mobility Exercises: (10 Minutes) 
 To mobilize the upper chest and shoulders -The patient is seated and the 
shoulders are flexed to 180 degrees with slight abduction (hands up) with inspiration 
and bend forward at the hips and reach the floor during  expiration.(5 times per 
session) 
Trunk Rotation- Patient in standing position and rotate the trunk to both sides in 
corporation   PLB (5 times per session). 
 
  GROUP B (Experimental Group):   
  Received conventional treatment for 40 minutes, along with oscillatory positive 
expiratory pressure device acapella which included for 20 minutes. 
 
Acapella Device: 
Procedure: 
                 Select the device (the acapella is available in two color coded models).   
The green acapella is high frequency model for patients able to                              
maintain an expiratory flow for 15 LPM or greater for three seconds.     The blue 
acapella is low frequency model for patients not capable of maintaining an expiratory 
flow of 15 LPM for 3 seconds. 
 
            With the first use of the acapella, ensure that the frequency adjustment dial is 
turned counter - clockwise to the lowest frequency - resistance setting. 
Frequency\Resistance increase clockwise. Selecting the proper resistance range 
produces the desired I: E ratio 1:3 to 1:4. 
 
         Place the mouth piece light in mouth; maintain a tight seal on the mouth piece 
during inspiration. Use/apply nose clip if necessary. Instruct the patient to relax 
performing diaphragmatic breathing. Patient should inspire the volume of air greater 
than normal tidal volume but less than total lung capacity. Instruct the patient to 
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slowly inhale ¾ maximum breathing capacities. Instruct the patient to hold breath 2-3 
seconds. Direct the patient to exhale to functional residual capacity (FRC) actively, 
but not too forcefully through the device. Emphasize the importance of inhaling 
slowly, breath holding and suppressing the urge to cough. The patient should be able 
to exhale for 3-4 seconds while the device vibrates if the patient cannot maintain an 
exhalation for this length of time, adjust the dial clockwise. Clockwise adjustment 
increases the resistance of the vibrating orifice, which will allow the patient to exhale 
at low flow rate. Perform 10-20 breaths. Remove mouth piece and perform 2-3 “huff” 
coughs to raise secretions as needed. Repeat the steps 4-10 as prescribed .This is 
repeated about 4 to 6 times for 10-20 minutes treatment. Document procedure and 
relevant findings on the respiratory progress notes in the therapy section of the chart. 
 
 The patient performed the acapella between 1-5 dialed settings, or a setting 
that was tolerated by the patient. The acapella settings were increased once the patient 
can achieve 3 seconds of continuous expiration. 
 
           The inspiratory phase is followed by a slow prolonged exhalation. 
Device is not gravity dependent and can be performed in conjunction with postural 
drainage. Device can be used in line with aerosol \nebulizer treatments. No care giver 
is needed once technique is mastered and independence promoted. 
 
Acapella Cleaning Instructions: 
 
 There are four parts to the device and it comes out easily.  Remove the mouth 
piece. Lift cover by pressing forefinger and thumb along ribbed surfaces by 
mouthpiece, it opens to a 90 degree angle. Gently remove cover from base. Lift out 
rocker assembly which is white, this is one piece. You should now have four 
individual parts. Soak in warm soapy water. Rinse thoroughly. Air dry all 4 parts do it 
not less than once weekly 
 
 
 
 
 21
3.2.11 Procedure 
            Prior sanction was obtained from the authorities to conduct the study. All 
patients after satisfying the inclusion criteria for the study .The patients and the 
bystanders are explained in detail about the procedure and the patients who are 
willing to take part in the study a consent form is signed by the patient itself. 
 
30 chronic asthma patients who are fulfilling the inclusion criteria will be 
assigned using non- probability convenient sampling and are randomly assigned into 
two groups namely control group (Group A) and experimental group (Group B).Each 
group contains 15 patients each. Group A receives conventional physiotherapy for 40 
minutes. Group B receives conventional physiotherapy for 40 minutes plus 20 
minutes of the acapella device to improve lung function.  
 
 The treatment schedule consists of 3 weeks, six days per week and  daily. The 
tool selected for pre-test and post-test measurements of pulmonary function testing 
was using the peak expiratory flow rate and for grading breathlessness, MRC dyspnea 
scale. 
  
OUTCOME MEASUREMENT  
     Assessment Procedure 
A) Peak Expiratory Flow Meter: To Use The PFM. 
1. Insert the mouth piece into the meter, if not already fitted. Ensure the pointer is set 
at zero (L/min). 
2. Hold the PFM so that your fingers are clear of the scale and slot. Do not obstruct 
the holes at the end of the PFM. 
3.  Stand up if possible (or) sitting  preferably, take a deep breath, place the peak 
flow meter in the mouth and hold horizontally, closing the lips around the mouth 
piece, then blow as hard and as fast as you can. 
4. Note the number on the scale indicated by the pointer. 
5. Return the pointer to zero (L/min) and repeat the procedure twice move to obtain 
three readings. Mark the highest of the three readings on your peak flow chart 
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6. Measure your peak flow rate close to the same time each day. You should record 
the PFR twice daily. 
7.  Keep a chart of your PFR. 
8. Chart the highest of the three readings. This is called “your personal best “ 
Measurement: 
 
The best of three readings is used as the recorded value of the peak expiratory flow 
rate. Peak flow readings are often classified into 3 zones of measurement according to 
the American Lung Association. 
.  
According to American Lung Association, green zone represents 80-100 %of your 
usual normal PFR signals all clear. Yellow zone represents 50-80% 0f your usual or 
normal PFR signals caution. Red zone indicates less than 50 % of your usual or 
normal PFR signals a medical alert. 
 
• MRC dyspnea scale is used to assess the severity of Asthma. 
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CHAPTER IV 
 
 DATA PRESENTATAION 
                         
 
GROUP: A – CONTROL GROUP 
                                                           
 
 
 
 
 
 
 
 
 
 
 
 PEAK EXPIRATORY FLOW RATE MRC DYSPNOE SCALE 
Sl. 
No. 
Pre Test                        Post Test Pre Test  Post Test 
1 300                         325 3 2 
2 290                         320 3 2 
3 305                         330 4 3 
4 310                         330 3 2 
5 295                         320 4 3 
6 290                         315 4 3 
7 315                         345 3 2 
8 300                         340 3 2 
9 320                         350 3 2 
10 315                         355 3 2 
11 325                         360 4 3 
12 295                         320 4 3 
13 310                         340 3 2 
14 330                         365 2 1 
15 325                         350 3 2 
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GROUP: B – EXPERIMENTAL GROUP 
 
 
 
 PEAK EXPIRATORY FLOW CHART MRC DYSPNOE SCALE 
Sl. No. Pre Test                        Post Test Pre Test  Post Test 
1 305                         375 3 1 
2 300                         360 4 2 
3 295                         355 4 2 
4 310                         390 3 1 
5 290                         360 4 2 
6 315                         370 3 1 
7 300                         365 3 1 
8 295                         360 3 1 
9 320                         400 3 1 
10 330                         410 2 1 
11 325                         400 3 1 
12 310                         390 3 1 
13 325                         400 2 1 
14 295                         360 4 2 
15 315                         385 4 2 
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CHAPTER V 
 DATA ANALYSIS AND INTERPRETATION 
           
Analysis of Post PEFR scores of control and experimental groups 
using two sample t test 
 
            TABLE 1 
 
 
Group 
 
N 
Post Test  
T 
Mean SD 
 
Control 
 
 
15 337.67   16.132 
 
 
6.438 
 
Experimental 
 
 
15 378.67 18.657 
 
 
For control group mean is 337.67 and standard deviation is 16.132 For the 
experimental group mean is 378.67 and standard deviation is 18.657 .The “t” value 
obtained is 6.438,which is statistically significant at 0.05 level of significance .The 
post PEFR scores of the control group are less than that of the scores of the 
experimental group. This means that the acapella along with conventional 
physiotherapy and conventional physiotherapy alone differ significantly in 
improving expiratory flow rates in chronic asthma 
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ANALYSIS OF POST MRC VALUES OF CONTROL AND 
EXPERIMENTAL GROUPS USING MANN- WHITNEY U TEST 
 
        TABLE 2          
 
Group 
 
N 
 
Mean Rank 
 
Sum of rank 
 
U 
 
Control 
 
 
15 
 
20.83 
 
312.50 
 
 
32.500 
 
Experimental 
 
 
15 
 
10.17 
 
152.50 
 
The post test scores taken at the end of 3 weeks treatment  
For the control group mean rank is 20.83, sum of rank is 312.50.For the experimental 
group mean rank is 10.17, and sum of rank is 152.50. ”U”value obtained is 32.500 
which are statistically significant at 0.05 level of significance. In this case post MRC 
scale of control group is greater than that of the corresponding scores at experimental 
group at 5% level of significance. There is significant difference between the post 
MRC scores of the two groups at 5% level of significance. This means that acapella 
along with conventional physiotherapy and conventional physiotherapy alone differs 
significantly in their effectiveness in improving breathlessness. 
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ANALYSIS OF PRE AND POST MRC VALUES OF CONTROL 
GROUP USING WILCOXON SIGNED RANK TEST 
 
     TABLE 3 
 
Score  
 
Mean 
 
N 
 
Mean Rank Sum of Rank Z 
Negative Positive Negative Positive 
 
 
Pre 
 
 
3.27 
 
 
 
15 
 
 
 
8.00 
 
 
 
0.00 
 
 
 
120.00 
 
 
 
0.00 
 
 
 
3.873 
 
 
Post 
 
   2.27  
 
15 
 
 
 
Mean pre test score for control group is 3.27 and mean post test score for  
Control group is 2.27. Z value obtained is 3.873. which is statistically significant at 
5%level of significance .That is the pre MRC score differ significantly from post 
MRC score at 5% level of significance .It can be seen that the MRC scale of post test 
score is less than pre test score at 5% level of significance .Data analysis shows 
significant improvement in breathlessness of experimental group .This might be due 
to the cumulative effect of conventional physiotherapy. 
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ANALYSIS OF PRE AND POST MRC VALUES OF 
EXPERIMENTAL GROUP USING WILCOXON SIGNED RANK 
TEST 
  
     TABLE 4 
Score  
 
Mean 
 
N 
 
Mean Rank Sum of Rank Z 
Negative Positive Negative Positive 
 
 
Pre 
 
 
3.20 
 
 
15 
 
 
 
8.00 
 
 
 
0.00 
 
 
 
120.00 
 
 
 
0.00 
 
 
 
3.690 
 
 
Post 
 
1.33 
 
15 
 
Mean pre test score for experimental group 3.20 and mean post test score for 
experimental group is 1.33. Z value obtained is 3.690. This is statistically significant 
at 5% level. That is the pre MRC score differs significantly from post MRC scores at 
5% level of significance.  It can be seen that the MRC scale post test score are less 
than pre test score at 5% level of significance.  Data analysis show significant 
improvement in breathlessness of experimental group.  This might be due to the 
oscillatory positive expiratory pressure along with conventional physiotherapy 
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      GRAPH 1 
 
Fig 1-shows the comparison of MRC values of both groups. The pre test of control 
group is 3.27 and post test score is 2.27 and pre test score of experimental group is 
3.20 and pre test score is 1.33 
There is significant difference between the pre and post MRC values at 5 % level of 
significance. The post MRC values are less than the pre MRC values. 
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ANALYSIS OF PRE AND POST PEFR SCORES OF 
CONTROL GROUP USING PAIRED‘t’ TEST 
     TABLE 5 
 
Group 
 
N 
PEFR SCORE  
 
T  Mean SD 
Pre Post Pre Post 
 
 
Control 
 
 
15 
 
308.33 
 
337.67 
 
13.184 
 
16.132 
 
 
19.138 
 
 
Mean pre test score for control group is 308.33 and mean post test score for control 
group is 337.67.”t” value obtained is 19.138.which is statistically significant at 5% 
level. Hence the pre PEFR differs significantly from post PEFR at 5% level of 
significance. Post PEFR scores are greater than the corresponding pre PEFR scores at 
5% level of significance. Data analysis shows significant improvement in expiratory 
flow rates in control group .This might be due to cumulative effect of conventional 
physiotherapy. 
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ANALYSIS OF PRE AND POST PEFR SCORES OF 
EXPERIMENTAL GROUP USING PAIRED‘t’ TEST 
     TABLE 6 
 
Group 
 
N 
PEFR SCORES  
 
T  Mean SD 
Pre Post Pre Post 
 
 
Control 
 
 
15 
 
308.67 
 
378.67 
 
12.743 
 
18.657 
 
 
32.911 
 
Mean pre test score for experimental group 308.67 and mean post test score for 
experimental group 378.67.”t” value obtained is 32.911.which is statistically 
significant at 5% level. The pre PEFR score differs significantly from post PEFR 
scores at 5% level of significance. Post PEFR scores are greater than the pre PEFR 
values at 5% level of significance. Data analysis shows significant improvement in 
pulmonary expiratory flow rates in experimental groups. This might be due to the 
cumulative effect of acapella along with conventional physiotherapy. 
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      GRAPH 2 
 
 
 
Fig-2 shows that comparison of PEFR values of both group’s .The pre test score of 
control group is 308.33 and post test score is 337.7 and pre test score of experimental 
group is 308.7 and post test score is 378.7 There is significant difference between the 
pre and post PEFR values at 5% level of significance .The post PEFR values are 
significantly greater than the pre PEFR values. 
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CHAPTER VI 
 
          DISCUSSION 
   
         The present study was a comparative experimental approach to find out the 
“Effectiveness of acapella along with conventional physiotherapy in improving lung 
function in patients with chronic asthma.” 
 
Thirty subjects who fulfilled the inclusion criteria were randomly assigned into 
Group A and Group B of 15 subjects each. The sample was selected using non-
probability convenient sampling technique. Here Group A receives conventional 
physiotherapy treatment which includes education, breathing Exercises, coughing, 
relaxation positioning, chest mobility exercises, and breath control techniques. Group 
B receives treatment with oscillatory positive expiratory pressure device - acapella 
along with conventional physiotherapy. The population for the study taken was 
chronic asthma patients using the chronic asthma questionnaire, residing in kottayam. 
The sample for the study was chronic asthma patients who attended the Department of 
Pulmonology, SH Medical Centre, Kottayam. 
 
The total treatment was given for 6 days a week for 3 weeks, the duration of each 
treatment session consisted of sixty minutes for experimental group and forty minutes 
for control group. The outcome measures selected were peak expiratory flow meter 
and the medical research council dyspnoea Scale; both groups were measured on the 
first and last day of the treatment. 
 
On statistical analysis of breathlessness and expiratory flow rates were done 
within the groups. Both the groups showed significant improvement in the expiratory 
flow rates and dyspnoea. Post-test analysis of control and experimental group shows 
statistically significant improvement in the expiratory flow rates and in 
breathlessness. 
 
In chronic asthma there may be persistent findings of hyperinflation with increase 
in TLC, reduced FEV1\FVC and VC. Dyspnoea, or laboured breathing, is associated 
with tachypnoea, or rapid breathing, as the patient attempts to maintain minute 
ventilation in the face of severe expiratory obstruction 
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. 
The airways widen normally during inspiration to allow the inflow of air. In 
asthma the normal airway narrowing during expiration is accentuated by obstruction, 
which prevents normal expiration. Gas that cannot be removed during expiration 
begins to accumulate in the lungs and hyperinflation is the result. Secondary or 
obstructive atelectasis is a common finding in patients with pulmonary disorders. 
Airway obstruction caused by copious or inspissated secretions, severe bronchial 
smooth muscle spasm, or significant edema of the bronchial wall in patients with 
chronic obstructive lung disease are capable of producing obstructive atelectasis. 
When complete obstruction is encountered in a bronchus that supplies air to a 
normally perfused area of lung parenchyma, the gas within the alveoli distal to the 
obstruction is absorbed into the pulmonary circulation. This process of absorption 
takes several hours or more. Once all alveolar gas has been absorbed into the 
circulation, the alveoli, now devoid of gas, collapse in a fashion similar to a balloon 
that has lost its air. 
 
Improvement in the expiratory flow rates and in breathlessness in the control 
group might have been due to breathing exercises, chest mobility exercises, and 
relaxation positioning and breath control during walking. 
 
Pursed lip breathing is thought to ease the work of breathing and shortness of 
breath. One theory benefits from pursed lip breathing is that, by providing slight 
resistance to expiration, the increased positive pressure generated within the airways 
helps to keep open or stent the bronchioles that otherwise collapse owing to loss of 
support associated with lung tissue destruction. This breathing pattern significantly 
decreased the respiratory rate and increased the tidal volume. 
 
Thoracic mobility exercises combine active movements of the trunk or extremities 
with deep breathing. These exercises combine stretching of the trunk muscles with 
deep breathing which improve ventilation. Chest mobilization exercises are also used 
to reinforce or emphasize the depth of inspiration or controlled expiration. A patient 
can improve expiration by leaning forward at the hips or flexing the spine as he or she 
breathes out. This pushes the viscera superiorly into the diaphragm and further 
reinforces expiration. 
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Relaxation is a well established as a therapy for asthma and is valued by patients; 
showed objective benefit by improved peak flow readings. 
 
Relaxation positioning will optimize the length tension status of the diaphragm 
.When the patient is sitting or standing, leaning forward or side lying, the abdominal 
contents raise the anterior part of the diaphragm, probably facilitating its contraction 
during inspiration. This effect, combined with relaxation of the head, neck and 
shoulder promotes the pattern of breathing control. 
  
Breath control is also used to improve exercise tolerance in breathless patients. 
The simple technique of relaxing the arms and shoulders, reducing the walking speed 
a little and using the pattern of breathing in on climbing one step and breathing out on 
climbing the next step can lead to a marked reduction in breathlessness and the ability 
to converse. 
 
The significant improvement in pulmonary function in experimental group over 
control group might be due to the effect of addition of oscillatory positive expiratory 
pressure device - acapella to the conventional treatment. 
 
Acapella is a small hand held device that combines the benefits of both positive 
expiratory pressure therapy and airway vibrations to mobilize pulmonary secretions. 
Acapella uses a counter weighted plug and magnet which directs exhaled air through 
a pivoting cone, to generate airflow vibrations between 0-30Hz.Both the vibrations 
frequency, and the resistive pressures are adjustable. Acapella combines the features 
of resistive pressure device and vibratory pressure device. Resistive pressure device 
works by using a pressurized breath to splint open the airway. Vibratory devices work 
by using oscillatory vibrations that travel into the lungs, shaking free mucus plugs that 
the patient can cough up. When the oscillation frequency approximates the resonance 
frequency of the pulmonary system, endobronchial pressure oscillations are amplified 
and results in vibrations of the airways. These vibrations loosen mucus from airway 
walls. 
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Exhalations through these devices generate oscillations of positive expiratory 
pressure in the airways and repeated accelerations of expiratory airflow that have been 
shown to result in improved sputum clearance. 
  
With the positive expiratory pressure on the peripheral airways and collateral 
channels, the increase in lung volume may allow air to get behind secretions blocking 
the small airways, and assist in mobilizing them. It was noticed that the use of 
acapella device, decreased the  sputum viscosity significantly overtime, such decrease 
in viscosity, facilitates airway reopening since a lower pressure is needed for this with 
a shorter time to achieve airway opening. Oscillations of positive airway pressure 
ventilation maintain open airways and enhance aeration to obstructed regions of the 
lung. 
  
Better oxygenation secondary to improved ventilation and reduced volume of 
trapped gas by using oscillatory positive expiratory pressure for chest physical 
therapy was reported. 
 
After conventional chest physical therapy there was significant improvement in 
the expiratory flow parameters and dyspnoea scores, whereas with the addition of 
acapella device there was a highly significant improvement in these parameters. This 
could be attributed to improved airways patency, promotion of airflow to and from 
previously obstructed airways and a resultant enhancement in mucus clearance from 
these areas. The acapella as well has shown to enhance collateral ventilation through 
pores of Kohn and the channels of Lambert .The positive back pressure generated 
during the use of acapella allows airflow to enter these channels behind areas of 
mucus obstruction, keeping the airways open during exhalation. This caused 
significant increase in effective ventilation, providing more alveolar area for 
distribution of inspired air, decreasing dead space and hence the pressures will be 
reduced and the compliance will increase. 
 
The acapella has shown to provide a combined effect of oscillatory vibrations 
and positive expiratory pressure. The theoretical benefits of positive pressure is the 
ability to enhance and promote mucus clearance by either preventing airway collapse 
by stenting the airways and increasing intrathoracic pressure distal to the retained 
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secretions by collateral ventilation. The use of OPEP technique was first described in 
Switzerland; it combines the above benefits of positive expiratory pressure with 
airway vibrations and oscillations. The theoretical benefits of OPEP have been 
described as a two fold increase in airway clearance. Indeed oscillations decrease the 
viscoelastic properties of mucus plugs, which make them easier to mobilize and create 
short bursts of increased expiratory airflow that assist in clearing secretions. In 
peripheral lung, where mucus plugs may block off the small airways and hence 
prevent normal ventilation of the alveolar gas exchange units, air movement may 
occur via the pores of Kohn. 
 
Acapella does not require gravity to work and will therefore work at any angle, 
so it can be used in positions comfortable to the patient. Acapella can also be used in 
postural drainage positions. 
 
Oral devices that apply positive end expiratory pressure maintain the patency of 
the airway during exhalation and accomplish many of the same goals as postural 
drainage in a shorter time and with less discomfort. 
 
According to Wegener et al (2003), any relatively effective method that is 
preferred by the patient may increase participation in routine airway clearance 
.Several published studies with small patient populations and of short duration has 
demonstrated oscillatory positive expiratory therapy to be equivalent to chest 
physiotherapy. 
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CHAPTERVII 
 
         RESULT 
 
      The purpose of the comparative experimental study was to examine the 
effectiveness of the acapella device and conventional physiotherapy to improve lung 
function in patients with chronic asthma. The population included the patients 
diagnosed as chronic asthma. Those patients were randomly assigned into control 
group and experimental group of 15 each.  Control group received conventional 
physiotherapy including breathing exercises, education, relaxation techniques, chest 
mobility exercises, and breath control during walking. The experimental group 
received acapella in addition to conventional physiotherapy. Pre-test evaluation was 
done on the first day prior to treatment and post test evaluation was done on the last 
day of treatment. The tools selected for measuring the outcome of the study were 
MRC dyspnoea scale and peak expiratory flow rate. 
 
The results obtained was statistically analyzed using  Mann- Whitney ‘ U’ Test, 
Two Sample ‘t’ Test, Paired ‘t’ Test, and Wilcoxon signed rank test. The result 
showed that experimental group had a significant improvement in expiratory flow 
rates and reduce breathlessness than the control group. 
 
           While comparing the post test PEFR values of control group and experimental 
group using two – sample‘t’ test, the calculated value is, 6.438 which is statistically 
significant to 0.05 significance level and comparing the post MRC values of control 
and experimental group using Mann-Whitney U test Z value is 3.609 which is 
significant to 0.05 significance level since the alternative hypothesis is accepted 
which shows that there exists a significant difference between the post test values of 
two groups. 
     When comparing the mean values of both, post test mean value of control 
group 337.67 using PEFR experimental group 378.67 using PEFR there is significant 
improvement, which confirms that experimental group shows significant 
improvement than control group. 
            When comparing post MRC values using Wilcoxon Signed rank test the 
control group Z value is 3.873 and experimental group is 3.690, there is significant 
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difference between the post values, which confirms that experimental group shows 
improvement than control group. 
 Results obtained from statistical analysis between pre test and post test values 
of experimental group at 5% level of significant showed significant improvement in 
PEFR values and MRC Scale following Acapella and conventional physiotherapy. 
These results suggest that Acapella along with conventional physiotherapy is effective 
in reducing dyspnea and improving lung function.  
 Since the alternative hypothesis is accepted Acapella along with conventional 
physiotherapy is more effective than conventional physiotherapy in improving lung 
function in patients with chronic asthma 
          The result of the present study revealed that both groups demonstrated 
significant improvement in pulmonary function, but it was more noted in 
experimental group who received treatment with oscillatory positive expiratory 
pressure device. Hence the result can be summarized as treatment with acapella along 
with conventional therapy is effective in improving pulmonary function and reducing 
dyspnoea in patients with chronic asthma.  
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         CHAPTER VIII 
 
   CONCLUSION 
 
              
The study proves that the acapella device is more effective than conventional 
physiotherapy alone in improving lung function and breathlessness in patients with 
chronic asthma. So acapella along with conventional physiotherapy can be used as an 
effective treatment programme in chronic asthma .Thus patients can improve their 
quality of life. 
 
Hence taking into account the positive results of the study it can be concluded 
that the acapella device can be self-administrative, is cost effective and can be used in 
any reclined positions in the management of chronic asthma patients. 
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CHAPTER IX 
 
 LIMITATIONS AND SUGGESTIONS 
 
                Limitations  
1. Size of the sample was very small which might have affected the outcome. 
2. The study was of short duration. 
3. Frequency of attacks was not recorded. 
4.  It was not able to assess the other psychological aspects of the patients. 
 
 
               Suggestions  
1. A large sample size is required to establish the effect of treatment. 
2. To make the result more valid, a long term study may be carried out. 
3. Regular follow up program can be included to know the long term effect of 
treatment. 
4. Similar study can be conducted, to know the effectiveness of oscillatory 
positive expiratory pressure device (acapella) in patients with other COPD; 
using appropriate outcome measures. 
5. Study can be conducted by using different outcome measures like FEV1, FVC, 
and FEV 1\FVC ratio, to evaluate the reliability of oscillatory positive 
expiratory pressure device -acapella in improving pulmonary function in 
patients with chronic asthma. 
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CHAPTERXII 
 APPENDIX 
       APPENDIX – 1 
CASE ASSESSMENT PROFORMA 
CASE SHEET NO    : 
NAME    : 
AGE      : 
SEX      : 
ADDRESS     : 
CHIEF COMPLIANT  : 
PAST MEDICAL HISTORY  : 
PRESENT MEDICAL HISTORY : 
PERSONAL HISTORY   : 
ON OBSERVATION   : 
ON EXAMIATION   : 
DIAGNOSIS    : 
MODE OF EXERCISE   : 
MEASUREMENT TOOL  :  
MRC SCALE
PRE TEST POST TEST
   
 
PEAK EXPLARATORY RATE
PRE TEST POST TEST
 
 
                                                                         Signature of physical therapy student 
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                                    APPENDIX – II 
                      PATIENT CONSENT FORM 
 
TITLE: A COMPARATIVE STUDY ON EFFECTIVENESS OF 
ACAPELLA ON IMPROVING LUNG FUNCTION IN CHRONIC 
ASTHMA 
INVESTIGATOR: _ _ _ _ _ _ _ _ _ _ _ 
PURPOSE OF THE STUDY: 
I_ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _  ,have been informed that this study will work 
towards achieving on the functional activities of daily living in post-stroke 
conditions for me and other patients. 
PROCEDURE: 
Each term of the study protocol has been explained to me in detail. I 
understand that during the procedure, I will be receiving the treatment for one 
time a day. I understand that I will have to take this treatment for four weeks. 
I understand that this will be done under investigator, _ _ _ _ _ _ _ _ _ _ _ _ _ 
_ _ supervision. I am aware also that I have to follow therapist’s instructions 
as has been told to me. 
CONFIDENTIALITY:    
 I understand that medical information provided by this study will be 
confidential. If the data are used for publication in the medical literature or for 
teaching purposes, no names will be used and other literature such as audio or 
video tapes will be used only with permission. 
RISK AND DISCOMFORT: 
I understand that there are no potential risks associated with this procedure, 
and understand that investigator will accompany me during this procedure. 
There are no known hazards associated with this procedure. 
REFUSAL OR WITHDRAWL OF PARICIPATION: 
I understand that the decision my participation is wholly voluntary and I may 
refuse participate, may withdraw consent at any time during the study. 
I also understand that the investigator may terminate my participation in the 
study at anytime after researcher has explained me the reasons to do so. 
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I _ _ _ _ _ _ _ _ _ _ _ _ _ _ have explained to 
…………………………………. the purpose of the research, the 
procedures required and the possible risks and benefits, to the best of my 
ability. 
……………………………………                         …………………………… 
Investigator                                               Date 
I ………………………………. Confirm that researcher has explained me 
the purpose of the research, the study procedure and the possible risks 
and benefits that I may experience. I have read and I have understood 
this consent to participate as a subject in this research project. 
……………………..                                          ………………………… 
Subject                                                         Date    
………………………..                                       …………………………. 
Signature of the Witness                          Date  
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APPENDIX- III  
   
THE MEDICAL RESEARCH COUNCIL DYSPNOEA 
SCALE   [ATS] 
 
GRADE  
I Not troubled by breathlessness except on 
strenuous exercises 
2 Short of breath when hurrying on the level 
or walking up a slight hill 
3 Walk slower than people of the same age on 
the level because of breathlessness or have 
to stop for breath when walking at  own 
pace on the level 
4 Stops for breath after walking about 100 
yards or after a few minutes on level ground
5 Too breathless to leave the house, or 
breathless when undressing 
 
Strenuous Exercises: Activities that includes difficult tasks like lifting heavy 
weights, walking up hill, stair climbing, playing sports, bicycling, jogging etc. 
ATS- American Thoracic Society  
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APPENDIX -IV 
   CHRONIC ASTHMA QUESTIONNAIRE 
Name:     Age:     Sex: 
QUESTION RESPONSE CHOICES 
1. Have you had wheezing or whistling in your chest at 
any time? 
Yes                   No 
2. Have you been woken up at night by an attack of 
coughing? 
Yes                 no 
3. Have had an attack of shortness of breath that came 
on during the day when you were at rest? 
Yes                no 
4. Have you had felt breathless that came on following 
strenuous activity at any time? 
Yes                no 
5. Do you have any pets at home? Yes                no 
 
6. Do you have any triggering symptoms of coughing, 
wheezing, or shortness of breath, when exposed to 
dust, pollens, molds, cold air, and humidity and 
weather changes? 
 
Yes                No 
7. Do you have mucous in your chest when you cough? 
If you have is it usually clear---------,  
Discoloured---------------? 
Yes              No 
8. Have you been to any pulmonologist during the last 
few years (lung doctor) if yes for how long you have 
been going? 
 
Yes               No 
9. Have you been using any reliever medications or 
inhalers or any bronchodilator drugs? 
 
Yes                  No 
 
10. How old were you when you had the attack? -------
-------------------- Have you had 2 or more such 
episodes since then? --------------------- 
 
Yes              No 
 
 
 
 
